Percutaneous coronary interventions and cardiovascular outcomes for patients with chronic total occlusions
E Marc Jolicœur1, Micheal J Sketch, Daniel M Wojdyla
1Duke University Medical Center, Durham, North Carolina, USA. marc.jolicoeur@icm-mhi.org
Insights
Successful recanalization of coronary chronic total occlusions (CTOs) did not improve survival in patients with stable coronary artery disease. Further analysis confirmed no significant association between CTO intervention success and patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- The clinical benefits of percutaneous recanalization for coronary chronic total occlusions (CTOs) remain debated.
- Assessing the true impact of CTO intervention requires careful adjustment for patient characteristics and procedural success.
Purpose of the Study:
- To evaluate the benefits of coronary chronic total occlusion (CTO) recanalization in stable coronary artery disease.
- To adjust for patient case-mix and propensity for CTO intervention when assessing outcomes.
Main Methods:
- A propensity score was derived from 1,602 patients undergoing percutaneous coronary intervention (PCI), comparing those who attempted CTO recanalization (n=346) versus those who did not (n=1,256).
- The primary analysis examined the association between successful CTO recanalization and survival free of death and cardiovascular rehospitalizations.
- Sensitivity analyses adjusted for propensity score, anatomical predictors of failure, and extent of revascularization.
Main Results:
- Successful CTO recanalization was not significantly associated with improved survival free of death and cardiovascular rehospitalization (Hazard Ratio = 0.90, 95% CI 0.64-1.25).
- Sensitivity analyses yielded even more conservative estimates, reinforcing the primary finding.
Conclusions:
- Percutaneous recanalization of coronary chronic total occlusions (CTOs) is not linked to improved survival in contemporary patients with symptomatic coronary artery disease.
- These findings suggest that the benefits of successful CTO recanalization on long-term survival may be limited in this patient population.
Objectives:
This study sought to assess the benefits of a coronary chronic total occlusion CTO recanalization after adjusting for the case-mix and the propensity to undergo the CTO intervention in a population of patients with stable coronary artery disease.
Background:
The benefits of percutaneous recanalization of CTO are disputed.
Methods:
In 1,602 patients with a least one CTO and treated by percutaneous coronary intervention (PCI), we derived a propensity score to undergo a CTO recanalization by comparing the characteristics of patients who did (n = 346) and did not (n = 1,256) undergo a CTO PCI attempt. Among the patients who underwent a CTO PCI attempt, we identified the angiographic predictors of failure. The primary analysis was ultimately performed by looking at the association between the outcome of the CTO recanalization and the survival free of death and cardiovascular rehospitalizations. Sensitivity analyses were performed by adjusting for the propensity to undergo a CTO recanalization, for the anatomical predictors of failure, and for the extent of coronary artery revascularization achieved.
Results:
A successful CTO recanalization was not significantly associated with survival free of death and cardiovascular rehospitalization (HR = 0.90, 95% CI 0.64-1.25). Even more conservative hazards ratio point estimates were obtained with the sensitivity analyses.
Conclusions:
Successful percutaneous CTO recanalization is not associated with survival free of death and cardiovascular hospitalizations in a contemporary population of patients with symptomatic coronary artery disease.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

